Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,080
-10 (-0.10%)
Apr 29, 2026, 3:30 PM KST
56.77%
Market Cap 113.82B
Revenue (ttm) 590.89B
Net Income (ttm) 10.93B
Shares Out 11.29M
EPS (ttm) 967.00
PE Ratio 13.22
Forward PE n/a
Dividend 100.00 (0.99%)
Ex-Dividend Date Mar 30, 2026
Volume 23,792
Average Volume 30,962
Open 10,090
Previous Close 10,090
Day's Range 9,900 - 10,130
52-Week Range 5,890 - 17,170
Beta 0.37
RSI 46.43
Earnings Date May 13, 2026

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 72
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

In 2025, Ildong Holdings's revenue was 590.89 billion, a decrease of -6.90% compared to the previous year's 634.65 billion. Earnings were 10.93 billion, a decrease of -82.67%.

Financial Statements

News

There is no news available yet.